Breaking News Instant updates and real-time market news.

ADMS

Adamas Pharmaceuticals

$32.15

-1.88 (-5.52%)

16:42
01/08/18
01/08
16:42
01/08/18
16:42

Adamas Pharmaceuticals announces U.S. launch of GOCOVRI

Adamas Pharmaceuticals announced the full commercial launch of its flagship product, GOCOVRI extended release capsules, for the treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications. GOCOVRI was approved by the U.S. FDA in August 2017, when it was granted seven years of orphan drug exclusivity, and has been available for physician and patient use since October 2017. This launch marks the deployment of Adamas' dedicated team of 59 neurology field sales professionals, who are focused on educating the Parkinson's disease community about the benefit/safety profile of GOCOVRI.

ADMS Adamas Pharmaceuticals
$32.15

-1.88 (-5.52%)

10/30/17
10/30/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Sotheby's (BID) initiated with a Buy at Aegis. 2. Alnylam (ALNY) initiated with a Buy at FBR Capital. 3. Adamas Pharmaceuticals (ADMS) initiated with an Outperform at Evercore ISI. 4. Vipshop (VIPS) initiated with a Neutral at UBS. 5. Rhythm Pharmaceuticals (RYTM) initiated with a Buy at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/29/17
NORL
11/29/17
INITIATION
Target $70
NORL
Outperform
Adamas Pharmaceuticals initiated with an Outperform at Northland
Northland analyst Carl Byrnes initiated Adamas Pharmaceuticals with an Outperform and $70 price target. The analyst said Adamas' GOCOVRI is a breakthrough in treating Parkinson's patients that have developed dyskinesia as a result of long-term exposure to levodopa therapy and sees peak sales exceeding $750M.
12/13/17
COWN
12/13/17
NO CHANGE
Target $55
COWN
Outperform
Adamas Pharmaceuticals named a best idea for 2018 at Cowen
Cowen analyst Ken Cacciatore views shares of Adamas Pharmaceuticals as "meaningfully undervalued" at current levels. He calls the stock a best idea for 2018 and keeps an Outperform rating on the name with a $55 price target. The analyst is confident that Gocovri, which is now on the market, will find a "significant place" in the Parkinson's disease treatment paradigm. He says Adamas has successfully developed an extended release amantadine for the treatment of levodopa-induced dyskinesia in patients with Parkinson's disease.
12/19/17
PIPR
12/19/17
NO CHANGE
Target $52
PIPR
Overweight
Adamas Pharmaceuticals price target raised to $52 from $35 at Piper Jaffray
Piper Jaffray analyst David Amsellem raised his price target for Adamas Pharmaceuticals to $52 saying his survey of 27 neurologists who treat a significant number of patients with epilepsy yielded "encouraging early feedback" on ADS-4101. The feedback suggests a relatively high degree of enthusiasm for a next-generation form of lacosamide, Amsellem tells investors in a research note. He views ADS-4101 as a "relatively underappreciated longer-term value driver" for Adamas and keeps an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

TRNC

tronc

$19.53

0.3 (1.56%)

16:26
01/19/18
01/19
16:26
01/19/18
16:26
Periodicals
LA Times' CEO Ross Levinsohn to take leave of absence amid probe, DJ says »

Dow Jones added that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RKDA

Arcadia Biosciences

$0.27

0.0285 (11.88%)

16:25
01/19/18
01/19
16:25
01/19/18
16:25
Conference/Events
Arcadia Biosciences to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

FB

Facebook

$181.29

1.49 (0.83%)

16:23
01/19/18
01/19
16:23
01/19/18
16:23
Hot Stocks
Facebook provides update on trusted sources initiative »

Starting next week,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 31

    Jan

  • 07

    Feb

  • 28

    Feb

MS

Morgan Stanley

$57.46

1.62 (2.90%)

, APO

Apollo Global

$34.74

-0.33 (-0.94%)

16:21
01/19/18
01/19
16:21
01/19/18
16:21
Hot Stocks
Morgan Stanley reports 5% passive stake in Apollo Global »

In a regulatory filing,…

MS

Morgan Stanley

$57.46

1.62 (2.90%)

APO

Apollo Global

$34.74

-0.33 (-0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 01

    Feb

HBNC

Horizon Bancorp

$28.49

0.37 (1.32%)

16:19
01/19/18
01/19
16:19
01/19/18
16:19
Syndicate
Breaking Syndicate news story on Horizon Bancorp »

Horizon Bancorp files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SANM

Sanmina

$35.45

0.5 (1.43%)

16:18
01/19/18
01/19
16:18
01/19/18
16:18
Hot Stocks
Breaking Hot Stocks news story on Sanmina »

Sanmina down 15% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SANM

Sanmina

$35.45

0.5 (1.43%)

16:17
01/19/18
01/19
16:17
01/19/18
16:17
Hot Stocks
Sanmina adopts consolidated restructuring plan »

On January 12, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$162.37

-6.75 (-3.99%)

, AXP

American Express

$98.03

-1.83 (-1.83%)

16:17
01/19/18
01/19
16:17
01/19/18
16:17
General news
On The Fly: Top stock stories for Friday »

Stocks were mixed for…

IBM

IBM

$162.37

-6.75 (-3.99%)

AXP

American Express

$98.03

-1.83 (-1.83%)

GE

General Electric

$16.26

-0.51 (-3.04%)

FB

Facebook

$181.29

1.49 (0.83%)

NCNA

NuCana

$20.51

6.02 (41.55%)

ACOR

Acorda Therapeutics

$27.20

2.2 (8.80%)

BIIB

Biogen

$342.41

-2.03 (-0.59%)

IPHI

Inphi

$32.07

-3.33 (-9.41%)

MKC

McCormick

$99.19

-3.72 (-3.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 23

    Jan

  • 24

    Jan

  • 25

    Jan

  • 25

    Jan

  • 31

    Jan

  • 07

    Feb

  • 07

    Feb

  • 28

    Feb

  • 08

    Mar

$NSD

NASDAQ Market Internals

16:17
01/19/18
01/19
16:17
01/19/18
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

16:16
01/19/18
01/19
16:16
01/19/18
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENDP

Endo

$7.11

-0.24 (-3.27%)

, CVS

CVS Health

$79.85

0.5 (0.63%)

16:15
01/19/18
01/19
16:15
01/19/18
16:15
Periodicals
Delaware files lawsuit against opioid manufacturers, distributors, Reuters says »

Delaware has become the…

ENDP

Endo

$7.11

-0.24 (-3.27%)

CVS

CVS Health

$79.85

0.5 (0.63%)

WBA

Walgreens Boots Alliance

$76.47

0.47 (0.62%)

MCK

McKesson

$170.33

-1.45 (-0.84%)

CAH

Cardinal Health

$71.90

0.19 (0.26%)

ABC

AmerisourceBergen

$100.01

-0.85 (-0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 06

    Feb

  • 08

    Feb

ITI

Iteris

$7.49

0.03 (0.40%)

16:12
01/19/18
01/19
16:12
01/19/18
16:12
Hot Stocks
Neil Subin sells $748K in Iteris shares »

Neil Subin, a beneficial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

SANM

Sanmina

$35.45

0.5 (1.43%)

16:11
01/19/18
01/19
16:11
01/19/18
16:11
Earnings
Sanmina sees Q2 adjusted EPS 40c-50c, consensus 70c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SANM

Sanmina

$35.45

0.5 (1.43%)

16:09
01/19/18
01/19
16:09
01/19/18
16:09
Earnings
Sanmina reports Q1 preliminary adjusted EPS 48c, consensus 71c »

Reports Q1 preliminary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$332.26

-0.74 (-0.22%)

16:07
01/19/18
01/19
16:07
01/19/18
16:07
Periodicals
Breaking Periodicals news story on Lockheed Martin »

U.S. approves sale of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 07

    Mar

CPLA

Capella Education

$80.50

0.7 (0.88%)

, STRA

Strayer

$93.08

0.9 (0.98%)

16:06
01/19/18
01/19
16:06
01/19/18
16:06
Hot Stocks
Capella Education shareholders approve proposed merger with Strayer »

Capella Education (CPLA)…

CPLA

Capella Education

$80.50

0.7 (0.88%)

STRA

Strayer

$93.08

0.9 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 19

    Jan

ADM

Archer Daniels

$40.61

0.13 (0.32%)

, BG

Bunge

$69.78

0.14 (0.20%)

16:03
01/19/18
01/19
16:03
01/19/18
16:03
Periodicals
Archer Daniels made takeover approach to Bunge, WSJ says »

Archer Daniels Midland…

ADM

Archer Daniels

$40.61

0.13 (0.32%)

BG

Bunge

$69.78

0.14 (0.20%)

GLNCY

Glencore

$11.29

-0.02 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 14

    Feb

C

Citi

$78.16

0.77 (0.99%)

16:01
01/19/18
01/19
16:01
01/19/18
16:01
Conference/Events
Citigroup to hold a conference call »

CFO Gerspach and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 24

    Jan

GOLF

Acushnet Holdings

$21.50

0.65 (3.12%)

16:01
01/19/18
01/19
16:01
01/19/18
16:01
Hot Stocks
Acushnet Holdings acquires Linkgs & Kings, terms not disclosed »

Acushnet Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BG

Bunge

$69.79

0.145 (0.21%)

, ADM

Archer Daniels

$40.66

0.18 (0.44%)

15:58
01/19/18
01/19
15:58
01/19/18
15:58
Hot Stocks
Breaking Hot Stocks news story on Bunge, Archer Daniels »

Bunge jumps 10% after…

BG

Bunge

$69.79

0.145 (0.21%)

ADM

Archer Daniels

$40.66

0.18 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 14

    Feb

BG

Bunge

$69.76

0.12 (0.17%)

, ADM

Archer Daniels

$40.66

0.18 (0.44%)

15:57
01/19/18
01/19
15:57
01/19/18
15:57
Periodicals
Breaking Periodicals news story on Bunge, Archer Daniels »

Archer Daniels made…

BG

Bunge

$69.76

0.12 (0.17%)

ADM

Archer Daniels

$40.66

0.18 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 14

    Feb

HGT

Hugoton Royalty Trust

15:57
01/19/18
01/19
15:57
01/19/18
15:57
Hot Stocks
Breaking Hot Stocks news story on Hugoton Royalty Trust »

Hugoton Royalty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSA

Comcast

$41.85

0.17 (0.41%)

15:50
01/19/18
01/19
15:50
01/19/18
15:50
Options
Bullish option play in Comcast ahead of earnings next week »

Bullish option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

SLB

Schlumberger

$76.33

-0.0384 (-0.05%)

15:35
01/19/18
01/19
15:35
01/19/18
15:35
Recommendations
Schlumberger analyst commentary  »

Schlumberger price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

HGT

Hugoton Royalty Trust

15:35
01/19/18
01/19
15:35
01/19/18
15:35
Hot Stocks
Breaking Hot Stocks news story on Hugoton Royalty Trust »

Hugoton Royalty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.